Trials / Withdrawn
WithdrawnNCT03371862
Liraglutide on Decreasing Parenteral Support in Short Bowel Patients (SLIPS)
Pilot Study of the GLP-1 Agonist, Liraglutide, on Decreasing Parenteral Support Requirements in Short Bowel Patients.
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Imperial College London · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Pilot study looking at the effect on Liraglutide in the reduction of parenteral support in patients with short bowel.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Liraglutide Pen Injector [Victoza] | Pilot study of liraglutide in patients with short bowel. |
Timeline
- Start date
- 2017-10-20
- Primary completion
- 2020-08-06
- Completion
- 2020-09-30
- First posted
- 2017-12-13
- Last updated
- 2020-08-14
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT03371862. Inclusion in this directory is not an endorsement.